COVID-19

progress in the development of our candidates for vacccines, diagnostics and therapies against COVID-19 is monitored here

Informing about product development processes

While a wide range of research on interventions targeting COVID-19 is conducted, limited information on progress and results is currently shared. 

We believe that transparent and consistent sharing of progress in product development  can accelerate efforts aimed at fighting COVID-19. Information sharing may not only improve the quality of developed medical solutions but also enable faster development and cost savings as a result of synergies across activities by governments, corporations and regulators alike. 
 
In this section, we will hence shortly provide an overview of our COVID-19 candidates' progress. 

How it works

On a regular basis, we will collect status quo updates from our product candidates, process all gathered information and translate it into progress indicators. These will be displayed in a comprehensive progress dashboard and provide a general overview on their respective status for expert and general audiences alike. 

The progress dashboard will go live here shortly.